Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus

Product Details
Customization: Available
CAS No.: 104987-11-3
Formula: C44h69no12
Still deciding? Get samples of US$ 100/g
Request Sample
Diamond Member Since 2012

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Number of Employees
11
Year of Establishment
2012-08-09
  • Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus
  • Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus
  • Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus
  • Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus
  • Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus
  • Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3  Tacrolimus
Find Similar Products

Basic Info.

Model NO.
104987-11-3
EINECS
1308068-626-2
Type
API
Appearance
Powder
Quality
Pharmaceutical Grade
Colour
White
Melting Point
113-115 Ceicius Degree
Density
1.19 g/cm3(Predicted)
Storage
Sealed in Dry, Store in Freezer, Under -20 Ceicius
Transport Package
as Required
Specification
USP-40
Trademark
Worldyang
Origin
China
HS Code
2941909099

Product Description

Product Name: Tacrolimus
CAS: 104987-11-3
Appearance: White Powder
Purity: 99% USP 40
Certificates: ISO9001:2015; GMP

Overview
Tacrolimus is a macrolide antibiotic with potent immunosuppressive effects, widely used in preventing organ transplant rejection and treating autoimmune diseases. It works by inhibiting calcineurin phosphatase, suppressing T-cell activation and cytokine production. Compared to cyclosporine, tacrolimus offers stronger immunosuppressive effects with fewer side effects. In daily life, tacrolimus can also be used to treat moderate to severe atopic dermatitis in cases where the immune system is not compromised.

Mechanism of Action
Tacrolimus binds to FKBP-12 within T-cells, forming a complex that inhibits calcineurin activation. This suppression prevents interleukin-2 (IL-2) synthesis and T-cell infiltration into grafts, effectively reducing rejection risk. Its superior graft survival rates, better tolerance, and lower rejection incidence have made it a cornerstone in organ transplantation.

The research team used synthetic biology technology to reconstruct the production bacteria and fermentation process for precise optimization, and obtained high-yield and stable production bacteria; The separation and purification process has been restructured, and impurities of homologous substances have been basically eliminated. The total impurities of the raw material are far below 1.0%, meeting the USP-40 standard. The project has been granted multiple domestic and foreign invention patents and has independent intellectual property rights.


Factory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 TacrolimusFactory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 TacrolimusFactory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 TacrolimusFactory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 TacrolimusFactory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 TacrolimusFactory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 TacrolimusFactory Supply USP 40 Microbial Fermentation Method CAS 104987-11-3 Tacrolimus

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier